WLF Chides Use Of False Claims Act To Prosecute Drug Manufacturers
This article was originally published in The Pink Sheet Daily
The federal government has other tools, such as the anti-kickback statute, to prevent manufacturers from using improper promotional practices, Washington Legal Foundation's Samp says.
You may also be interested in...
Serono Inc., which reached a $704 mil. settlement with federal and state prosecutors, says its brand products will remain available under federal healthcare programs despite the guilty plea by its U.S. affiliate.
Two of the leading medical journals are offering opposing viewpoints on mandatory human papilloma virus vaccination, with experts contributing perspective pieces that directly reflect the larger political and social division over the issue
FDA's "not approvable" action on Merck's Vioxx follow-on Arcoxia for the treatment of symptoms of osteoarthritis could be indicative of a conservative regulatory climate at the agency